Publication | Closed Access
Inhibition of monoacylglycerol lipase, an anti-inflammatory and antifibrogenic strategy in the liver
84
Citations
30
References
2018
Year
MAGL is an immunometabolic target in the liver. MAGL inhibitors may show promising antifibrogenic effects during chronic liver injury.
| Year | Citations | |
|---|---|---|
Page 1
Page 1